Abstract
The endothelins are among the most potent vasoconstrictors known. Pharmacological inhibition of endothelin receptors lowers blood pressure (BP). It is unknown whether naturally occurring genetic variation in the endothelin receptors influences BP. We have evaluated the type A endothelin receptor (EDNRA) as a candidate gene for hypertension in a large family study. A total of 1425 members of 248 families selected via a proband with hypertension were studied. Ambulatory BP monitoring was conducted using the A&D TM2421 device. Four haplotype-tagging single nucleotide polymorphisms (SNPs) spanning the EDNRA gene were typed. There was evidence of association between genotype at the rs5335 (C+70G) SNP and night systolic blood pressure (+1.24% (s.e. 0.64) per G allele; P=0.05); night diastolic blood pressure (+1.64% (s.e. 0.71) per G allele; P=0.021) and night mean BP (+1.51% (s.e. 0.64) per G allele; P=0.017). Borderline significant trends in the same direction were seen for daytime BPs. Proportions of hypertensives in each of the three genotype groups were C/C 34.7%, C/G 37.9%, G/G 42.4% yielding an odds ratio for hypertension per G allele of 1.19 (95% confidence interval 1.00–1.41; P=0.05). In conclusion, the rs5335 (C+70G) polymorphism of the EDNRA gene has small effects on the risk of hypertension. Natural variation in other genes in the endothelin-signalling pathway should be explored to identify additional influences on BP regulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ward RH . Genetic and sociocultural components of high blood pressure. Am J Phys Anthropol 1983; 62 (1): 91–105.
Coats AJ, Radaelli A, Clark SJ, Conway J, Sleight P . The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992; 10 (4): 385–391.
Conway J, Johnston J, Coats A, Somers V, Sleight P . The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertens 1988; 6 (2): 111–116.
Cardon LR, Palmer LJ . Population stratification and spurious allelic association. Lancet 2003; 361 (9357): 598–604.
Campbell CD, Ogburn EL, Lunetta KL, Lyon HN, Freedman ML, Groop LC et al. Demonstrating stratification in a European American population. Nat Genet 2005; 37 (8): 868–872.
Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004; 36 (4): 388–393.
Spieker LE, Noll G, Ruschitzka FT, Luscher TF . Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J Am Coll Cardiol 2001; 37 (6): 1493–1505.
Serneri GGN, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A et al. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ Res 2000; 86 (4): 377–385.
Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53 (4): 1029–1034.
Keavney B, Bird R, Caiazza A, Casadei B, Conway J . Measurement of blood pressure using the auscultatory and oscillometric methods in the same cuff deflation: validation and field trial of the A&D TM2421 monitor. J Hum Hypertens 2000; 14 (9): 573–579.
Wigginton JE, Abecasis GR . PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21 (16): 3445–3447.
Abecasis GR, Cherny SS, Cookson WO, Cardon LR . Merlin—rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30 (1): 97–101.
Phillips MS, Lawrence R, Sachidanandam R, Morris AP, Balding DJ, Donaldson MA et al. Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat Genet 2003; 33 (3): 382–387.
Tobin MD, Sheehan NA, Scurrah KJ, Burton PR . Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24 (19): 2911–2935.
Abecasis GR, Cardon LR, Cookson WO . A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66 (1): 279–292.
Stevens P, Brown MJ . Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 1995; 26 (3): S9–S12.
Benjafield AV, Katyk K, Morris BJ . Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension. Clin Genet 2003; 64 (5): 433–438.
Ormezzano O, Poirier O, Mallion JM, Nicaud V, Amar J, Chamontin B et al. A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J Hypertens 2005; 23 (11): 2019–2026.
Iemitsu M, Maeda S, Otsuki T, Sugawara J, Tanabe T, Jesmin S et al. Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects. Hypertension 2006; 47 (5): 928–936.
Nicaud V, Poirier O, Behague I, Herrmann S-M, Mallet C, Troesch A et al. Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: The etude cas-temoins sur l'infarctus du myocarde (ECTIM) study. Am J Hypertens 1999; 12 (3): 304–310.
Hasegawa KFH, Doyama K, Inada T, Ohtani S, Fujiwara T, Hosoda K et al. Endothelin-1-selective receptor in the arterial intima of patients with hypertension. Hypertension 1994; 3: 288–293.
Campia U, Cardillo C, Panza JA . Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation 2004; 109 (25): 3191–3195.
Brown LA, Nunez DJ, Brookes CI, Wilkins MR . Selective increase in endothelon-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat. Cardiovasc Res 1995; 29: 768–774.
Kassab S, Miller MT, Novak J, Reckelhoff J, Clower B, Granger JP . Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 1998; 31: 397–402.
Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP . Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001; 37: 485–489.
Allcock GH, Venema RC, Pollock DM . ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Am J Physiol Regul Integr Comp Physiol 1998; 275 (1): R245–R252.
Bird JE, Moreland S, Waldron TL, Powell JR . Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension 1995; 25 (6): 1191–1195.
Reinhart GA, Preusser LC, Opgenorth TJ, Wegner CD, Cox BF . Endothelin and ETA receptors in long-term arterial pressure homeostasis in conscious nonhuman primates. Am J Physiol Regul Integr Comp Physiol 2000; 279 (5): R1701–R1706.
Nakov R, Pfarr E, Eberle S, HEAT Investigators. An effective endothelin A receptor antagonist for treatment of hypertension. Am J Hypertens 2002; 15: 583–589.
Cardillo C, Kilcoyne CM, Waclawiw M, Cannon III RO, Panza JA . Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999; 33 (2): 753–758.
Acknowledgements
The genotyping of EDNRA was funded by the British Heart Foundation. The family collection was funded in 1993–96 by the Wellcome Trust.
Author information
Authors and Affiliations
Corresponding author
Additional information
No part of this work has been previously published or presented.
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Rahman, T., Baker, M., Hall, D. et al. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure: a family study. J Hum Hypertens 22, 282–288 (2008). https://doi.org/10.1038/sj.jhh.1002322
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002322
Keywords
This article is cited by
-
The glomerular filtration barrier: a structural target for novel kidney therapies
Nature Reviews Drug Discovery (2021)
-
Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation
The Pharmacogenomics Journal (2019)
-
Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening
Heart Failure Reviews (2014)
-
Effect of SNP Polymorphisms of EDN1, EDNRA, and EDNRB Gene on Ischemic Stroke
Cell Biochemistry and Biophysics (2014)
-
Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque
Nature Genetics (2011)